Back to top

LACOG 0116 – LATINO LUNG

  /    /  LACOG 0116 – LATINO LUNG

Prospective epidemiological study of metastatic Non Small Cell Lung Cancer (NSCLC) in Latin America

Type of Study: Epidemiological

Sponsor / Support: LACOG, BMS, Pfizer

Primary Objectives: To describe the overall survival of advanced NSCLC in Latin America A prospective and epidemiological

Design: 800 patients

Sample Size: Gustavo Werutsky

Principal Investigator: 

Countries LATAM: Argentina, Brazil, Colombia, Mexico and Uruguay